Application of operational tolerance signatures are limited by variability and type of immunosuppression in renal transplant recipients: A cross-sectional study.

Application of operational tolerance signatures are limited by variability and type of immunosuppression in renal transplant recipients: A cross-sectional study.

<h4>Background</h4> <p>Renal transplant recipients (RTR) frequently develop complications relating to chronic immunosuppression. Identifying RTR who could safely reduce immunosuppression is therefore highly desirable. We hypothesized that “signatures” described in RTR who have sto...

Полное описание

Библиографические подробности
Главные авторы:	Bottomley, M, Chen, M, Fuggle, S, Harden, P, Wood, K
Формат:	Journal article
Язык:	English
Опубликовано:	Lippincott, Williams and Wilkins 2016

Схожие документы

Defining a Methylation Signature Associated With Operational Tolerance in Kidney Transplant Recipients
по: Ramon M. Rodriguez, и др.
Опубликовано: (2021-08-01)

Update on the long-term complications of renal transplantation.
по: Bottomley, M, и др.
Опубликовано: (2013)

Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and associates with malignancy risk in long-term renal transplant recipients
по: Bottomley, M, и др.
Опубликовано: (2022)

Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients
по: Mysore K. Phanish, и др.
Опубликовано: (2020-03-01)

The prevalence of hyperlipidemia in renal transplant recipients. Associations with immunosuppressive and antihypertensive therapy.
по: Bittar, A, и др.
Опубликовано: (1990)

Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and may associate with malignancy risk in long-term renal transplant recipients
по: Bottomley, MJ, и др.
Опубликовано: (2022)

Evaluation of the XM-ONE assay and the role of endothelial cell antibodies in recipients of living donor renal transplants
по: Procter, J, и др.
Опубликовано: (2009)

Fatal complications of long-term immunosuppressive therapy in a renal transplant recipient
по: I G Rekhtina, и др.
Опубликовано: (2008-07-01)

Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients
по: Matthew J. Bottomley, и др.
Опубликовано: (2022-07-01)

Comparative analysis of induction immunosuppressive therapy protocols in renal transplant recipients (retrospective review)
по: Sh. R. Galeev, и др.
Опубликовано: (2020-07-01)

Evaluation of the XM-ONE (R) assay and the role of endothelial cell antibodies in recipients of living donor renal transplants
по: Procter, J, и др.
Опубликовано: (2009)

Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression.
по: Ratcliffe, P, и др.
Опубликовано: (1996)

Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project)
по: Alessandro C. Rosa, и др.
Опубликовано: (2023-10-01)

Laryngeal cryptococcosis; a condition reported in renal transplant recipients and other immunosuppressed patients
по: Alfonso J. Rodriguez-Morales, и др.
Опубликовано: (2017-04-01)

The utilisation of biomarkers of a reduced immune response to predict squamous cell carcinoma in long-term renal transplant recipients
по: Bottomley, M
Опубликовано: (2015)

BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression
по: Katherine A. Barraclough, и др.
Опубликовано: (2011-01-01)

Prevalence of nonmalignant cutaneous disease in renal transplant recipients
по: Lally, A, и др.
Опубликовано: (2006)

Comparison of glucose tolerance in renal transplant recipients and hemodialysis patients
по: Rahbaninobar Mohammad, и др.
Опубликовано: (2004-09-01)

The Clinical Manifestation of Immunosuppressive Therapy as a Tool to Improve Immune Monitoring in Renal Transplant Recipients
по: Noa Scott, и др.
Опубликовано: (2023-05-01)

Oxidative and nitrosative stress in stable renal transplant recipients with respect to the immunosuppression protocol: Differences or similarities?
по: Cvetković Tatjana, и др.
Опубликовано: (2015-01-01)

Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and Wales
по: Muduma G, и др.
Опубликовано: (2014-11-01)

Successful Late Conversion to Mycophenolate Mofetil and Prednisone Immunosuppression Therapy in a Renal Transplant Recipient
по: Iqbal A, и др.
Опубликовано: (2000-01-01)

Interdyscyplinary management of verrucous carcinoma in renal transplant recipient on long term immunosuppression. Clinical report.
по: Jacek Pliszczynski, и др.
Опубликовано: (2020-09-01)

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients
по: Brook, MO, и др.
Опубликовано: (2022)

Development and validation of the first consensus gene-expression signature of operational tolerance in kidney transplantation, incorporating adjustment for immunosuppressive drug therapy
по: Sofia Christakoudi, и др.
Опубликовано: (2020-08-01)

Immunosuppression after the diagnosis of renal allograft renal cell carcinoma in two transplant recipients: Case reports and review of the literature
по: Joyita Bharati, и др.
Опубликовано: (2021-01-01)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
по: Koen G. A. M. Hussaarts, и др.
Опубликовано: (2021-01-01)

Variability in the reporting of renal function endpoints in immunosuppression trials in renal transplantation: time for consensus?
по: Knight, S, и др.
Опубликовано: (2016)

Evidence for the Immunosuppressive Potential of Calcineurin Inhibitor-Sparing Regimens in Liver Transplant Recipients with Impaired Renal Function
по: Kentaro Ide, и др.
Опубликовано: (2011-01-01)

Identification of Immunosuppressive Medication Nonadherence Factors Through a Combined Theory Model in Renal Transplant Recipients
по: Pengpeng Zhang, и др.
Опубликовано: (2021-05-01)

Elimination of BK viremia in renal transplant recipients by optimization of immunosuppressive medications without precipitating acute rejection
по: Amitabh Jha, и др.
Опубликовано: (2018-01-01)

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients
по: Susan Dutton, и др.
Опубликовано: (2022-04-01)

Impacts on Donor-Recipient HLA Matching on Operational Tolerance Following Pediatric Living-Donor Liver Transplantation
по: Ohe, H, и др.
Опубликовано: (2011)

A national survey of immunosuppression adjustment in elderly lung transplant recipients
по: Jade M Kozuch, и др.
Опубликовано: (2024-12-01)

Rapid Development of Syringocystadenocarcinoma Papilliferum in an Immunosuppressed Liver Transplant Recipient
по: Catherine Zilberg, и др.
Опубликовано: (2022-05-01)

Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study
по: Andreas Krisl, и др.
Опубликовано: (2020-12-01)

Tacrolimus-Based Immunosuppressive Therapy Influences Sex Hormone Profile in Renal-Transplant Recipients—A Research Study
по: Dagmara Szypulska-Koziarska, и др.
Опубликовано: (2021-07-01)

Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression
по: V. Ram Peddi, MD, и др.
Опубликовано: (2023-02-01)

Predictors of cancer risk in the long-term solid-organ transplant recipient.
по: Sherston, SN, и др.
Опубликовано: (2014)

Psychosocial Variables Associated with Immunosuppressive Medication Non-Adherence after Renal Transplantation
по: Jennifer Felicia Scheel, и др.
Опубликовано: (2018-02-01)